scholarly journals SEXUAL DYSFUNCTION;

2017 ◽  
Vol 24 (06) ◽  
pp. 888-892
Author(s):  
Muhammad Adnan Bawany ◽  
Abdul Aziz Sahito ◽  
Falak Naz ◽  
Adnan Ali Khahro ◽  
Rabail Bohio ◽  
...  

Objectives: To determine the frequency of sexual dysfunction in the patientssuffering from chronic liver disease. Period: 1 year from June 2013 to May 2014. Study Design:An observational study. Setting: Asian Institute of Medical Sciences. Methodology: 150 casesof chronic liver disease including patients of both genders at Asian Institute of medical scienceswho had suggestive history and signs /symptoms of sexual dysfunction. Results: Study found51.3% of total patients were suffering with sexual dysfunction. Out of all participating females,52.2% were affected and among the total male patients 51% males were suffering from sexualdysfunction. Hepatitis C virus (HCV) and Hepatitis B virus (HBV) were positive in 76.7% and11.3%, respectively. Conclusion: Sexual dysfunction is a common complication in the patientssuffering from chronic liver disease.

2021 ◽  
Vol 2021 ◽  
pp. 1-14
Author(s):  
Behailu Terefe Tesfaye ◽  
Temesgen Mulugeta Feyissa ◽  
Azmeraw Bekele Workneh ◽  
Esayas Kebede Gudina ◽  
Mengist Awoke Yizengaw

Background. In Ethiopia, chronic liver disease (CLD) is the 7th leading cause of death, accounting for about 24 deaths per 100000 populations in 2019. Despite its burden, there is a lack of compiled pieces of evidence on CLD in the country. Thus, this systematic review and meta-analysis is intended to provide the pooled estimates of CLD etiologies and mortality rate in CLD patients in Ethiopia. Method. PubMed, Google Scholar, ScienceDirect, institutional repositories, national digital library, and the bibliography of the eligible articles information were the source of data for the present review. The keywords “hepatitis, chronic” [Mesh], “end-Stage Liver Disease” [Mesh], “chronic liver disease”, “liver cirrhosis” [Mesh], and “Ethiopia” were used for the searches. Overall, we retrieved 199 records and 12 were included in this review. We used the DerSimonian-Laird random-effects models to perform the meta-analysis. We conducted subgroup and meta-regression analyses to account for the heterogeneity of the estimates. Result. Hepatitis B virus, alcohol, and hepatitis C virus are the three most common etiologies of CLD in Ethiopia accounting for a pooled estimate of 40.0% [95% CI: 29.0, 51.0, I2 = 96.3, p < 0.001 ], 17.0% [95% CI: 9.0, 25.0, I2 = 96.7, p < 0.001 ], and 15.0% [95% CI: 9.0, 21.0, I2 = 95.8, p < 0.001 ], respectively. Unidentified etiology report has a substantial contribution accounting for an estimated pooled proportion of 45% [95% CI: 34.0, 56.0%, Q = 32.08, p < 0.001 , I2 = 87.53] of the CLD cases in the country. On the other hand, the overall hospital mortality rate in CLD patients is 25.0% [95% CI: 2.0, 47.0, I2 = 94.6, p < 0.001 ] in Ethiopia. Conclusion. Hepatitis B virus, hepatitis C virus, and alcohol are the three most common contributors to CLD cases in Ethiopia. The authors warrant routine screening and strengthening of preventive and treatment programs for viral hepatitis B and C, further enhancing the alcohol policy of the country.


Intervirology ◽  
2008 ◽  
Vol 51 (1) ◽  
pp. 59-68 ◽  
Author(s):  
Mikako Obika ◽  
Toshiyuki Shinji ◽  
Shin-ichi Fujioka ◽  
Ryo Terada ◽  
Hiromasa Ryuko ◽  
...  

Hepatology ◽  
1994 ◽  
Vol 19 (4) ◽  
pp. 805-809 ◽  
Author(s):  
Santosh Man Shrestha ◽  
Fumio Tsuda ◽  
Hiroaki Okamoto ◽  
Hajime Tokita ◽  
Minoru Horikita ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A7-A7
Author(s):  
S ROSS ◽  
S MASCHERETTI ◽  
H HINRICHSEN ◽  
P BUGGISCH ◽  
U FOELSCH ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Shuhei Yoshikawa ◽  
Takeharu Asano ◽  
Mina Morino ◽  
Keita Matsumoto ◽  
Hitomi Kashima ◽  
...  

AbstractPruritus is known to be a common complication in hepatitis patients, but the exact frequency and degree are not fully elucidated. Thus, we evaluated pruritus of 450 patients with chronic liver disease at our hospital. Pruritus was observed in 240 (53%) of the patients. Pruritus was significantly associated with males (OR = 1.51, P = 0.038) and patients with alkaline phosphatase (ALP) ≥ 200 U/L (OR = 1.56, P = 0.0495) and was significantly less in HBsAg-positive patients (OR = 0.449, P = 0.004). Seasonally, there was no difference in the frequency of pruritus between summer and winter. Of the 24 refractory pruritus patients treated with nalfurafine, 17 (71%) indicated improvement of itch, which is defined as a decrease in the visual analog scale score ≥ 30 mm. Pruritus was improved by nalfurafine both during daytime and nighttime in the Kawashima’s scores evaluation. All patients who received nalfurafine exhibited improved Kawashima’s scores ≥ 1 point during the daytime or nighttime. In conclusion, pruritus occurred in > 50% of patients with chronic liver disease, and predictors of pruritus were males and ALP ≥ 200 U/L. Nalfurafine may be useful for pruritus, regardless of whether daytime or nighttime.


Sign in / Sign up

Export Citation Format

Share Document